Last updated: 2026-09-04 23:35:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
DexCom, Inc. (DXCM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $87.88, with a market capitalization of $33.85B and a P/E ratio of 33.86. Over the past 52 weeks, its price has ranged from $54.11 to $92.59. This page covers its latest market performance, valuation, price trends and company information.
$33.85B | |
$88.78 | |
$164.86 | |
$0.34 | |
$89.71 | |
1.83M | |
-- | |
33.86 | |
$92.59 | |
$54.11 | |
-- | |
-- |
DexCom, Inc. (DXCM) is trading at $88.11 in after-hours trading as of 2026-09-04 23:31:00, down 1.79% ($1.60) from the regular-session close of $89.71.
After-hours trading shows how investors are pricing DXCM after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, DexCom, Inc. (DXCM) moved from $90.00 to $87.88, representing a decline of 2.36% ($2.12).
The stock traded between $87.67 and $89.82 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 2.38 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 87.8%
DXCM is currently trading at $87.88, placing it 87.8% of the way from its 52-week low of $54.11 to its 52-week high of $92.59. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 11100 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DexCom, Inc. (DXCM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.